Monthly Archives: April 2013

Raising Funds for Research through Amazon

April 24th, 2013|

A Kids' Brain Tumor Cure is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means to earn advertising fees by linking to Amazon.com. If you shop with Amazon by clicking this link, the Foundation earns $$, which we will deploy for cutting edge scientific research.

 

Shop Amazon - Up to 50 Off Select Outdoor Toys

Research Evidence Suggests Tumors Can Be Targeted

April 17th, 2013|

A recent genomic study by researchers at St. Judes and Washington University Medical Center, identifies genetic mutations responsible for over half of low grade astrocytoma brain tumors. Researchers also found evidence that suggests that these tumors are susceptible to drugs that are already in development...read more

CHOP Study Confirms BRAF-Targeted Therapies For PLGA Are Possible

April 17th, 2013|

CHOP's recently published article entitled "Paradoxical activation and RAF inhibitor of BRAF protein kinase fusions characterizing pediatric astrocytomas", in PNAS, April 9th, 2013, confirms that data supported the development of targeted treatment paradigms for BRAF-altered pediatric actrocytomas and also demonstrated that therapies might be tailored to the specific mutational context and distinct mechanisms of action of the mutant kinase. read more

Guided-Missle Cancer Treatments Gaining Speed…

April 12th, 2013|

The Wall Street Journal's April 9th, 2013 article, The Guided-Missle Cancer Treatment", by Jonathan D. Rockoff, explains in 'layman' terms the current trend in identifying more effective treatments for cancer patients. This powerful new tool is also being used by researchers who are funded by A Kids' Brain Tumor Cure and the progress is encouraging. With additional investment, this strategy has the potential to significantly decrease the adverse effects of treatment by targeting the unhealthy cancer cells rather than healthy ones. Read more...